People often think of wastewater as serving no purpose. But it can be a valuable source of information. Wastewater is increasingly recognized as a significant environmental reservoir for antimicrobial resistance—a growing ...
May 25, 2023
0
2
The public is in favor of the development of bacteria-killing viruses as an alternative to antibiotics—and more efforts to educate will make them significantly more likely to use the treatment, a new study published in ...
May 22, 2023
0
57
Researchers at St George's are leading an international clinical trial to evaluate much-needed new antibiotic combinations for newborn babies with sepsis, thanks to sponsorship from the Global Antibiotic Research and Development ...
May 22, 2023
0
2
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
May 16, 2023
0
50
Overuse of antibiotic prescriptions for patients with upper respiratory illnesses at urgent care clinics in the United States has been an ongoing challenge, but a new study led by researchers at two Utah health systems—Intermountain ...
May 11, 2023
0
38
Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant. For some patients, like those with blood cancer, however, there is a risk that the bacteria will travel into the ...
May 9, 2023
0
10
A new test revealed that FDA-approved antibiotics—available at your neighborhood pharmacy—can effectively treat superbugs. They are not prescribed, however, because the gold-standard test predicts they will not work. ...
Apr 27, 2023
0
35
The EU on Wednesday unveiled a long-awaited proposed reform of legislation governing pharmaceutical drugs to make them cheaper, prevent shortages and boost new antibiotic production.
Apr 26, 2023
0
4
Patients hospitalized with pneumonia typically stay on IV antibiotics until they're stable, after about three days, but a new study suggests a different option.
Apr 25, 2023
0
2
Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus—a bacterial species widely resistant ...
Apr 24, 2023
0
70
